Our broad spectrum of clients in healthcare includes hospitals, healthcare systems, medical centers, and laboratories. We offer counsel on regulatory compliance, clinical business, litigation, reimbursement, privacy and security, real estate, and supply chain, as well as the complexities of fraud, antitrust, and tax.

Our international biotechnology and pharmaceuticals practice, comprising more than 80 attorneys, patent agents, and science advisers, is dedicated to supporting the mission of our clients to develop and commercialize innovative products and services to diagnose, prevent, and treat disease and improve people's health. 

Our team counsels clients in the medical device and med tech fields, including startups, major manufacturers, and academic institutions. We cover innovations spanning cardiovascular, optics, renal care, surgical tools, and beyond.

In providing patent, and corporate counsel to life science startups, pharmaceutical companies, and research-oriented institutions, Perkins Coie lawyers combine their profound legal expertise with robust technical acumen. 

Many of our life sciences lawyers hold advanced degrees in molecular biology, chemistry, or biophysics, with areas of focus including: 

• Artificial intelligence and machine learning diagnostic tools and drug discovery. 
• Antibody, peptibody, and ADC therapeutics.  
• Biologics and biosimilars. 
• Cancer diagnostics, therapeutics, and vaccines. 
• Cellular therapeutics. 
• Diagnostics. 
• Gene editing, including CRISPR technology. 
• Gene therapy, including nonviral and viral gene delivery. 
• Genetic testing, including cfDNA diagnostics and NIPT. 
• Genetically engineered cells and microorganisms. 
• Immunology, including autoimmune treatment and diagnostics. 
• Immunotherapy, including CAR-T and TCR therapy. 
• Microfluidics, microplates, and microarrays. 
• Oncology. 
• Nanotechnology. 
• Nucleic acid sequencing and multiplex screening. 
• NexGen and Third Gen sequencing. 
• Peptide design and therapeutics. 
• Personalized medicine/precision medicine. 
• Pharmaceuticals. 
• Protein identification, characterization, and therapeutics. 
• Small molecule identification, synthesis, and therapeutics. 
• Stem cell generation, modification, and therapy. 
• Targeted drug delivery. 
• Viral diagnostics, therapeutics, and vaccines, including COVID-19. 

We have expanded the reach of our industry knowledge through our publications, blogs, and engagement with industry associations, as well as by serving on the boards of directors of multiple life sciences organizations.